These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37755425)

  • 1. Preventing measles in children and adolescents with HIV.
    Kaur G; Perry RT
    AIDS; 2023 Nov; 37(13):2087-2089. PubMed ID: 37755425
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles vaccination in HIV-infected children.
    Rose VL; Preboth M
    Am Fam Physician; 1999 Nov; 60(7):2179. PubMed ID: 10569516
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi.
    Fowlkes A; Witte D; Beeler J; Audet S; Garcia P; Curns A; Yang C; Fudzulani R; Broadhead R; Bellini WJ; Cutts F; Helfand RF
    J Infect Dis; 2011 Jul; 204 Suppl 1():S149-57. PubMed ID: 21666156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
    Moss WJ; Scott S; Mugala N; Ndhlovu Z; Beeler JA; Audet SA; Ngala M; Mwangala S; Nkonga-Mwangilwa C; Ryon JJ; Monze M; Kasolo F; Quinn TC; Cousens S; Griffin DE; Cutts FT
    J Infect Dis; 2007 Aug; 196(3):347-55. PubMed ID: 17597448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV vs. measles.
    Westly E
    Sci Am; 2011 May; 304(5):26. PubMed ID: 21595399
    [No Abstract]   [Full Text] [Related]  

  • 6. Measles immunization in HIV-infected children. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS.
    Pediatrics; 1999 May; 103(5 Pt 1):1057-60. PubMed ID: 10224192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children.
    al-Attar I; Reisman J; Muehlmann M; McIntosh K
    Pediatr Infect Dis J; 1995 Feb; 14(2):149-51. PubMed ID: 7746699
    [No Abstract]   [Full Text] [Related]  

  • 8. Measles, mumps and rubella immunisation in children at risk of infection with human immunodeficiency virus.
    Molyneaux PJ; Mok JY; Burns SM; Yap PL
    J Infect; 1993 Nov; 27(3):251-3. PubMed ID: 8308316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection.
    Brunell PA; Vimal V; Sandu M; Courville TM; Daar E; Israele V
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):540-8. PubMed ID: 8548333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles Seroprevalence and Vaccine Responses in Human Immunodeficiency Virus-infected Adolescents and Adults: A Systematic Review.
    Loevinsohn G; Rosman L; Moss WJ
    Clin Infect Dis; 2019 Aug; 69(5):836-844. PubMed ID: 30452621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measles vaccination in HIV infected children].
    Ołdakowska A; Marczyńska M
    Med Wieku Rozwoj; 2008; 12(2 Pt 2):675-80. PubMed ID: 19418943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV's challenge to measles control.
    Katz SL
    Clin Infect Dis; 2007 Dec; 45(11):1425-6. PubMed ID: 17990223
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
    Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.
    Chandwani S; Beeler J; Li H; Audet S; Smith B; Moye J; Nalin D; Krasinski K;
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S179-89. PubMed ID: 21666159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)-Unexposed and HIV-Exposed, Uninfected South African Children.
    Mutsaerts EAML; Nunes MC; Bhikha S; Ikulinda BT; Boyce W; Jose L; Koen A; Moultrie A; Cutland CL; Grobbee DE; Klipstein-Grobusch K; Madhi SA
    J Infect Dis; 2019 Sep; 220(9):1529-1538. PubMed ID: 31282539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postvaccinal immunity study of children inoculated with a live measles vaccine].
    Bol'shakova SL
    Tr Inst Im Pastera; 1979; 53():75-8. PubMed ID: 162466
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of specific prophylaxis against measles].
    Andzhaparidze OG; Gordienko HM; Sokolova TM; Dorofeev VM
    Vestn Akad Med Nauk SSSR; 1975; (4):27-33. PubMed ID: 1220365
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.
    Waibale P; Bowlin SJ; Mortimer EA; Whalen C
    Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles seroprevalence and vaccine response in HIV-infected adults.
    Wallace MR; Hooper DG; Graves SJ; Malone JL
    Vaccine; 1994 Oct; 12(13):1222-4. PubMed ID: 7839728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles outbreak in South Africa, 2003-2005.
    McMorrow ML; Gebremedhin G; van den Heever J; Kezaala R; Harris BN; Nandy R; Strebel P; Jack A; Cairns KL
    S Afr Med J; 2009 May; 99(5):314-9. PubMed ID: 19588791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.